Ancora Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Ancora Advisors’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,000	Closed	-$720K	–	1515
2020 Q1	$720K	Buy	+15,000	New	+$698K	0.03%	378

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Ancora Advisors's RARX Position: Q2 2020 in Review

Ancora Advisors sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 15,000 shares — an estimated $720K sold.

Ancora Advisors first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $720K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Ancora Advisors reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Ancora Advisors sold 15,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $720K.
Ancora Advisors first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Ancora Advisors's Ra Pharmaceuticals, Inc. Common Stock position peaked at $720K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Ancora Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.